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Abstract
Purpose To compare the performance of one-view digital breast tomosynthesis (1v-DBT) to that of three other protocols
combining DBT and mammography (DM) for breast cancer detection.
Materials and methods Six radiologists, three experienced with 1v-DBT in screening, retrospectively reviewed 181 cases (76
malignant, 50 benign, 55 normal) in two sessions. First, they scored sequentially: 1v-DBT (medio-lateral oblique, MLO), 1v-
DBT (MLO) + 1v-DM (cranio-caudal, CC) and two-view DM+DBT (2v-DM+2v-DBT). The second session involved only 2v-
DM. Lesions were scored using BI-RADS® and level of suspiciousness (1–10). Sensitivity, specificity, receiver operating
characteristic (ROC) and jack-knife alternative free-response ROC (JAFROC) were computed.
Results On average, 1v-DBT was non-inferior to any of the other protocols in terms of JAFROC figure-of-merit, area
under ROC curve, sensitivity or specificity (p>0.391). While readers inexperienced with 1v-DBT screening improved
their sensitivity when adding more images (69–79 %, p=0.019), experienced readers showed similar sensitivity (76 %)
and specificity (70 %) between 1v-DBT and 2v-DM+2v-DBT (p=0.482). Subanalysis by lesion type and breast density
showed no difference among modalities.
Conclusion Detection performance with 1v-DBT is not statistically inferior to 2v-DM or to 2v-DM+2v-DBT; its use as a stand-
alone modality might be sufficient for readers experienced with this protocol.
Key points
• One-view breast tomosynthesis is not inferior to two-view digital mammography.
•One-viewDBT is not inferior to 2-viewDM plus 2-viewDBT.
• Training may lead to 1v-DBT being sufficient for screening.
Keywords Digital breast tomosynthesis . Digital mammography . Breast cancer . Receiver operating characteristic . Jack-knife
alternative free-response receiver operating characteristic
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Introduction
Digital breast tomosynthesis (DBT) improves breast cancer de-
tection and diagnosis compared to digital mammography (DM)
[1–9]. Instead of resulting in a two-dimensional (2D) image of
the compressed breast as in DM, DBTacquires several low-dose
2D projections over a limited angular range, which are then used
to reconstruct a pseudo-3D image of the breast [10]. Therefore,
DBT can ameliorate the main limitation of DM: the anatomical
noise due to tissue superposition. After years of promising results
pointing to its superiority to DM, DBT is now being considered
to be used for population-based breast cancer screening [11].
However, there is no agreement regarding how to implement
DBT in screening.
Some implementations of DBT involve its use as an ad-
junct to DM. The main arguments for performing DM in ad-
dition to DBT are comparisons with prior mammograms, as
well as results of some early studies that suggest that DBT is
inferior for calcification detection and characterization [12,
13]. However, the primary negative effects of performing both
modalities are an increase in reading time [14, 15] and in
radiation dose [16]. The replacement of DM with synthetic
2D mammograms generated from DBT volumes allows for
comparison with priors and reduces the radiation dose, while
providing similar diagnostic performance to DM [17–19].
With regard to calcification detection, new studies indicate
that DBT is not inferior to DM even for wide-scan angle
DBT systems (those acquiring the projection images over an
angular range of 40–50°, more prone to blurring due to a more
oblique x-ray incidence) [20]. Thus, the ongoing evolution of
the technique suggests the possibility of using DBTas a stand-
alone modality.
However, the vast technical differences among com-
mercial systems may need to be considered [10]. Using
a wide-scan angle DBT system yields improved depth
information [21]. Therefore, these systems better exploit
the 3D advantage of DBT over DM, and may make the
acquisition of two views of the breast unnecessary. A
large screening trial has recently shown that using only
the medio-lateral oblique (MLO) view of a wide-scan an-
gle DBT system as a one-view stand-alone technique re-
sulted in a 43 % breast cancer detection increase com-
pared to two-view DM [7], supporting earlier pilot studies
[22, 23]. Other preliminary studies also showed that one-
view DBT is not significantly different to two-view DM,
but they used a subject sample that was enriched, either
totally [24, 25] or partially [26], with lesions detected
with standard 2v-DM, therefore only allowing for a deter-
mination of non-inferiority for DBT.
In our study, we aim to further explore the potential of one-
view DBT for breast cancer detection in screening, by
performing a retrospective reader study with an enriched case
dataset, comparing the clinical performance of one-view DBT
(1v-DBT, MLO) with three other protocols: 1v-DBT (MLO)
plus 1v-DM (CC), two-view DM (2v-DM) and 2v-DM plus
2v-DBT, something not yet reported in the same study.
Furthermore, we also evaluate the strengths of 1v-DBT as a
standalone technique stratified by lesion type, breast density
and radiologist experience in reading 1v-DBT in a screening
setup, which has not yet been studied.
Methods
Study population
This retrospective study was approved by the regional ethics
board after summary review, with waiver of a full review and
informed consent. The study used DM and DBT images from
181 women (median age 52 years, range 30–88 y) imaged at
our hospital between December 2014 and December 2015,
who were recalled from screening (33 %) or had a clinical
indication for imaging (67 %). All the available cancer cases
within the collection date were included, while benign and
normal cases were consecutively included to meet the propor-
tions described below. Women with a prior history of breast
cancer or for whom the required views for this study were
unavailable were excluded (in total, 25). Within the cohort,
76 patients had malignant lesions and 50 had benign lesions,
all verified by histopathology. Four patients had multiple le-
sions, three patients with two different malignant lesions and
one patient with one benign and one malignant lesion. In total,
130 lesions were diagnosed with histopathological proof (79
malignant, 51 benign). The remaining 55 patient cases were
interpreted as normal (Breast Imaging Reporting and Data
System, BI-RADS®, score 1 or 2), and had at least 1 year of
negative imaging follow-up (mean follow-up: 378 days).
Detailed characteristics of patient cases and identified lesions
are presented in Table 1. Density according to BI-RADS® 5th
Edition was obtained from the radiological case report from
clinical routine.
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Patient images
All patients had undergone diagnostic breast imaging using a
commercial DBT system (Mammomat Inspiration, Siemens,
Erlangen, Germany). For each patient 2v-DM and 2v-DBT
(CC and MLO) were obtained. For DBT, the system acquires
25 low-dose projection images over an angular range of ap-
proximately 50° (wide-angle breast tomosynthesis) in about
25 s [10]. The projection images are subsequently reconstruct-
ed using a filtered back-projection algorithm [27]. Four differ-
ent unilateral (breast with the most suspicious findings, or
randomly selected if normal) image sets resembling four dif-
ferent imaging protocols were created for each patient: one-
view breast tomosynthesis (1v-DBT, MLO), 1v-DBT (MLO)
plus 1v-DM (CC), 2v-DM and 2v-DM plus 2v-DBT.
Study design
A retrospective reader study consisting of two reading ses-
sions (Fig. 1) was designed to evaluate the detection perfor-
mance of the four protocols. The first session had a sequential
design with three distinct steps per patient, where the readers
were shown progressively 1v-DBT (MLO) (step 1), then 1v-
DBT (MLO) plus 1v-DM (CC) (step 2) and finally 2v-DM
plus 2v-DBT (step 3). The second reading session was per-
formed at least 4 weeks (considered enough for a memory
washout period) after the first session and consisted of only
the 2v-DM images. A training set consisting of 20 cases was
reviewed to begin each session. The readers were blinded to
any information about the patient and any prior imaging.
At each step, the readerwas asked to annotate and score all the
detected suspicious lesions. For each abnormality, the observer
gave two scores: a forced BI-RADS® assessment (1 – normal, 2
– benign findings, 3 – low probability of malignancy, 4 - suspi-
cious of malignancy, 5 – highly suspicious of malignancy) as
established by the American College of Radiology, and a level
of suspiciousness score (10-point scale, from 1 – high probability
of benign; to 10 – high probability of malignancy).
The experiment was performed on an in-house developed
workstation (CIRRUS Observer, Diagnostic Image Analysis
Group, Nijmegen, The Netherlands) using dual 5-MP or one
10-MP mammographic display(s). The workstation also auto-
matically recorded reading times for each modality.
Reference standard
The reference standard, including location and lesion type, was
established by one radiologist who did not participate in the study
and had 13 years of experience in DM and 2 in DBT, with
knowledge of the clinical presentation, additional imaging tests
including priors and histopathology reports, when available.
Readers
Six breast radiologists performed the study. They are part of three
different institutions across two countries: The Netherlands and
Sweden. We recognized two distinct categorical groups of
readers; the three readers from The Netherlands, who had no
experience in reading 1v-DBT as a stand-alone modality for
breast cancer screening, and the three readers from Sweden,
who were experienced in this approach due to participation in a
large 1v-DBT screening trial [7]. The three experienced readers
with 1v-DBT had 3, 12 and 44 years of experience with mam-
mography and 3, 9 and 10 years of experience with DBT. The
Table 1 Characteristics of the patients and the lesions included in the
observer study
Patient characteristics
Cases (recalls from screening) 181 (60, 33 %)
Normal 55 (0, 0 %)
Biopsied benign 50 (24, 48 %)
Biopsied malignant 76 (36, 47 %)
Age
Median age (y) 52 (range 30–88)
< 40 15 (8 %)
40–49 51 (28 %)
50–59 66 (37 %)
60–69 33 (18 %)
≥ 70 16 (9 %)
BI-RADS Breast density
Almost entirely fatty 21 (12 %)
Scattered fibroglandular densities 78 (43 %)
Heterogeneously dense 62 (34 %)
Extremely dense 20 (11 %)
Biopsied lesion characteristics
Total biopsied lesions 130
Benign and high-risk lesions 51
Histology Lesion type
Fibroadenoma 17 With soft tissue 30
Hyperplasia 10
Fibrocystic changes 6
Single papilloma 3 With calcifications 24
Lobular carcinoma in situ 3
Others* 12
Malignant lesions 79
Histology Lesion type
Invasive ductal carcinoma 40 With
soft tissue
58
Ductal carcinoma in situ 18
Invasive lobular carcinoma 13 With calcifications 36
Invasive papillary carcinoma 3
Others† 5
*Examples are inflammation, adenosis, duct ectasia and benign
phylloides tumour
†Examples are tubular carcinoma, non-Hodgkin’s lymphoma, and neuro-
endocrine carcinoma
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three inexperienced readers with 1v-DBT had 17, 26 and 35
years of experience with mammography and 2, 2 and 3 years
of clinical experience with DBT in combo mode (2v-DM + 2v-
DBT).
Statistical analysis
Four different analyses were performed. First, for a precise eval-
uation, a jack-knife alternative free-response receiver operating
characteristic (JAFROC) analysis was performed [28]. For this,
the lesion localizations by the readers (considered correct if with-
in 2 cm of the reference standard) and the level of suspiciousness
were used. JAFROC provides a figure of merit (FoM) defined as
the probability that a correctly marked lesion is rated higher than
the highest-rated mark on a normal/benign case [29].
For the second analysis, receiver operating characteristic
(ROC) curves and their area under the curve (AUC) were com-
puted. Since ROC analysis requires that diagnostic confidence
is expressed in an ordinal scale, level of suspiciousness and not
BI-RADS® scores of the most suspicious finding per case were
used [30]. ROC analysis was repeated discriminating by lesion
type (soft tissue lesions or calcifications; if a lesion was com-
posed of both types, it was counted on each category) and breast
density category (low, a and b; or high, c and d).
Significance testing of ROC and JAFROC was performed
using the Dorfman–Berbaum–Metz multiple reader, multiple-
case mixed-model analysis of variance, which yields a p-value
for rejecting the null hypothesis that the four modalities have
equal performance. Random-reader and random-case analysis
was performed [28, 29, 31].
To study the impact that our results would have in a screening
scenario, sensitivity and specificity on a per-case basis were com-
puted using BI-RADS® categories, using BI-RADS® category
3 or higher defined as a positive interpretation. Cases with
biopsied benign lesions were considered as false positives if they
were rated positive by the readers. Average sensitivity and spec-
ificity for all imaging protocols were computed using a general-
ized linear model (GLM) to account for multiple reader, multiple
case repeated measures. Parameter estimates of the GLM were
bootstrapped (n=1,000). The all two-way GLMmodel was built
with an unstructured covariancematrix, usingmodality and read-
er as factors. To adjust for multiple comparison, the least signif-
icant difference correction was used. Model-based Wald 95 %
confidence intervals were calculated. Statistical significance
among modalities for each reader was estimated using
McNemar’s paired test.
Finally, reading times, defined as the time spent on evaluating,
scoring and annotating 1v-DBT (first step of the first reading
session) and 2v-DM (second reading session), were compared
using two-way repeated measures ANOVA. Outliers, defined as
times whose values extended beyond 1.5 standard deviations,
were removed. Also, mean glandular doses were retrieved from
theDICOM (Digital Imaging andCommunications inMedicine)
headers for comparison. Differences between modalities for each
reader were compared using a paired Student’s t-test.
A two-tailed p value lower than 0.05 was considered to
indicate significant difference. All analyses were performed
using SPSS (version 24, IBM Inc., Armonk, NY, USA) and
open-access JAFROC software by Dev Chakraborty (version
4.2.1, DevChakraborty.com).
Results
The JAFROC curves averaged for all readers are shown in
Fig. 2, while individual JAFROC FoM per reader and expe-
rience are shown in Table 2. There was no statistical difference
between 1v-DBT and the other protocols (p=0.522), either on
Fig. 1 Schematic of the study
design, where 1v-DBT (MLO)
was compared to 1v-DBT (MLO)
+ 1v-DM (CC), to 2v-DBT + 2v-
DM, and with respect to 2v-DM.
The study was carried out in two
different reading sessions, the first
one sequential, the second one at
least 4 weeks later
Fig. 2 JAFROC analysis averaged for all readers for each reading
protocol. The lesion localization fraction is the number of correctly
identified lesions divided by total number of lesions (0 ≤ LLF ≤ 1),
while the non-lesion localization fraction is the number of marks which
are not close to any lesions, divided by total number of images (0 ≤NLF);
note the lack of an upper bound
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average or per reader. The FoM for 1v-DBTwas similar to 2v-
DM and slightly lower than for the rest, while it was compa-
rable between experienced and inexperienced readers with 1v-
DBT. Only a small difference was found in the JAFROC FoM
between experienced and inexperienced observers, the latter
performing slightly better with 2v-DM. Relative results did
not change if the biopsied benign cases were removed from
the analysis, and 1v-DBT yielded similar performance to the
other three modalities (p=0.459).
The average radiologist’s ROC curve is shown in Fig. 3a for
each imaging protocol. TheAUCof 1v-DBTwas not statistically
significantly different than that of the other protocols for the
average of readers (p=0.391, Table 3 and Fig. 3a). Only in two
cases was 1v-DBT significantly different with respect to another
protocol: for one reader (experienced with 1v-DBT), the AUC
was statistically better for 1v-DBT than for 2v-DM (p=0.011),
while for another reader (inexperienced with 1v-DBT) 1v-DBT
performed worse than 2v-DM (p=0.035). Experienced readers
had only slightly higher AUCs for 1v-DBT than the inexperi-
enced readers (Fig. 3b; experienced = 0.815 (CI: 0.760-0.871),
inexperienced = 0.800 (CI: 0.746-0.855), not significant,
p=0.775). On the other hand, AUC for 2v-DM was lower
(p=0.425) in the experienced (0.793, CI: 716-0.871) compared
to the inexperienced group (0.831, CI: 775-0.887).
Using ROC analysis, no significant difference was found
between 1v-DBTand the other modalities either by separating
the cases by breast density (low, p=0.601; or high, p=0.323),
or by separating the lesions by type (soft tissue, p=0.329; or
calcifications, p=0.499). It was also seen that 1v-DBT per-
forms better than 2v-DM at low false-positive rates, both in
ROC (Fig. 3a) and JAFROC (Fig. 2) analyses.
The sensitivity and specificity per reader and on average
for each imaging protocol is shown in Table 4 and Fig. 4. No
difference was found between 1v-DBT and the other modali-
ties either for sensitivity (p=0.536) or specificity (p=0.553).
There were differences in the results among the six readers
(p<0.001). For the group of 1v-DBTexperienced radiologists,
there was no statistically significant difference either in sensi-
tivity (p=0.776) or specificity (p=0.482) between 1v-DBTand
the other protocols. For the inexperienced group, sensitivity
increased for all the other protocols with respect to 1v-DBT
(only significant for 2v-DM, from 69 % to 79 %, p=0.019),
while specificity was slightly higher for 1v-DBTwith respect
to the other protocols (not significant, p=0.777).
Table 2 JAFROC (jack-knife
alternative free-response receiver
operating characteristic) figure of
merit (FoM) per reader and by
reader group according to experi-
ence. The FoM is defined as the
probability that a malignant lesion
is rated higher than any mark on
an image which does not contain
malignancies (95 % CI is shown
within parentheses)
Reader 1v-DBT 1v-DBT+1v DM 2v-DBT+2v-DM 2v-DM
R1 0.782 0.788 0.805 0.759
R2 0.764 0.757 0.785 0.799
R3 0.731 0.760 0.760 0.770
R4 (exp) 0.767 0.773 0.784 0.773
R5 (exp) 0.745 0.763 0.760 0.717
R6 (exp) 0.774 0.788 0.796 0.760
Inexperienced with 1v-DBT 0.759
(0.692–0.825)
0.768
(0.706–0.831)
0.783
(0.720–0.847)
0.776
(0.709 –0.843)
Experienced with 1v-DBT 0.762
(0.700–0.825)
0.775
(0.713–0.837)
0.780
(0.717–0.844)
0.750
(0.680–0.820)
All 0.761
(0.699–0.822)
0.772
(0.711–0.832)
0.782
(0.721–0.842)
0.763
(0.699–0.827)
Fig. 3 Average receiver operating
characteristic (ROC) curves com-
puted with the level of suspi-
ciousness score of the highest
rated lesion on each case: (a) for
each imaging protocol consider-
ing all readers and (b) for 1v-DBT
differentiating by groups of expe-
rience with this protocol among
readers
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Two examples of cases that were correctly assessed by
most readers in 1v-DBT and not in 2v-DM are shown in
Figs. 5 and 6, while two cases assessed correctly by most
readers in 2v-DM and not in 1v-DBT are displayed in Figs.
7 and 8. Apparently, the effect DBTcan have in benign lesions
is bidirectional (Figs. 6, and 8), sometimes leading to in-
creased suspiciousness and recall and sometimes reducing
suspiciousness and avoiding recall.
The mean glandular dose per study was equal between 1v-
DBT (2.41 ± 0.87 mGy) and 2v-DM (2.41 ± 0.83 mGy). The
mean dose for 1v-DBT+1v-DMwas 3.62 ± 1.25 mGy and for
2v-DBT+2v-DM was 7.23 ± 2.49 mGy. The average reading
time was higher for 1v-DBT with respect to 2v-DM (55 s
versus 44 s, p<0.001, see Table 5). For three readers there
was no statistical difference between 1v-DBT and 2v-DM,
and no difference in reading time was found between experi-
enced and inexperienced observers. A total of 41 reading time
outliers were identified among all readers (median six outliers
per reader, range 2–15).
Discussion
The results of our study suggest that one-view digital breast
tomosynthesis is not significantly different than two-view
digital mammography and the combination of two-viewmam-
mography plus two-view tomosynthesis for breast cancer
detection.
The addition of 1v-DM (CC) to 1v-DBT (MLO), one of the
protocols recommended by some manufacturers, yielded an
increase in sensitivity but also a small decrease in specificity
for the inexperienced readers. For the readers experienced
with 1v-DBT, no increase in sensitivity was found when
adding 1v-DM to 1v-DBT, similar to the results by Lång
et al. [7]. In general, for experienced readers, 1v-DBT proved
to be enough in terms of sensitivity and specificity, and no
added value was found with extra views. The results of the
inexperienced 1v-DBT reader group were different. These ra-
diologists operate at a different point along the same ROC
curve as the experienced 1v-DBT reader group, either due to
local screening practices or due to their not being accustomed
to arriving at a decision with a single view. Overall, they had a
higher specificity and lower sensitivity for 1v-DBT, that re-
spectively decreased and increased when more images were
added. The higher specificity could be explained due to hav-
ing more experience in reading mammograms. However, their
performance in terms of ROC was similar to that of the expe-
rienced readers, suggesting that training could lead them to
operate at the same point as the more experienced readers with
1v-DBT.
Table 3 Area under the curve of the average receiver operating characteristic (ROC) curve for each of the studied imaging protocols. Parentheses
indicate 95 % confidence intervals
1v-DBT 1v-DBT+1v DM 2v-DBT+2v-DM 2v-DM
Average reader 0.808
(0.754–0.862)
0.818
(0.766–0.870)
0.830
(0.778–0.883)
0.812
(0.752–0.872)
Table 4 Sensitivity and
specificity (in %, within
parentheses 95 % Wald
confidence intervals) for the
average of all readers and grouped
by experience, using the BI-
RADS® score of the most
suspicions finding on each case
Reader 1v-DBT 1v-DBT+1v DM 2v-DBT+2v-DM 2v-DM
Sensitivity
R1 78 (68–87) 83 (74–92) 82 (73–90) 83 (74–92)
R2 66 (55–77) 71 (61–81) 76 (67–86) * 79 (70–88) *
R3 63 (52–74) 65 (53–75) 72 (62–83) * 74 (64–84) *
R4 (exp) 78 (68–87) 78 (68–87) 80 (71–89) 75 (65–85)
R5 (exp) 68 (58–79) 72 (62–83) 67 (56–78) 65 (53–75)
R6 (exp) 80 (71–89) 79 (70–88) 79 (70–88) 78 (68–87)
All 72 (68–76) 75 (71–79) 76 (72–80) 76 (72–80)
Specificity
R1 66 (56–75) 63 (53–72) 67 (58–76) 63 (53–72)
R2 84 (77–91) 79 (71–87) 84 (77–81) 82 (74–89)
R3 83 (76–90) 80 (72–88) 75 (67–84) * 82 (74–89)
R4 (exp) 68 (59–77) 66 (56–75) 65 (55–74) 73 (65–83)
R5 (exp) 77 (69–85) 76 (68–84) 78 (70–86) 78 (70–86)
R6 (exp) 66 (56–75) 66 (56–75) 67 (58–76) 71 (63–80)
All 74 (71–78) 72 (68–76) 73 (69–76) 76 (72–79)
*Significant (p-value <0.05) difference with respect to 1v-DBT
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These results are similar when taking lesion localization into
account and computing the figure-of-merit of the JAFROC anal-
ysis. Nevertheless, as could be expected, the protocol with more
images available for the radiologist, 2v-DBT plus 2v-DM, yielded
a slightly better, but not significant, performance.We also saw that
1v-DBT performs better than 2v-DMat low false positives, which
could be particularly relevant and important for screening.
The experience level with mammography might have also
played a role in our results. As suggested by some studies, the
least experienced readers with mammography benefit the
most from using DBT [26, 32]. In our case, we observed that
the less experienced readers with mammography had a lower
ROC performance with 2v-DM than the others, but similar
performance with 1v-DBT.
When looking at different lesion types, we found that 1v-
DBT is not statistically inferior to any other tested protocol for
the task of detecting lesions with calcifications, which adds to
the results by other authors [33, 26, 20] and suggests that DBT
is not inferior for the detection of calcifications even with a
wide-angle DBT system.
All these results suggest that the use of 1v-DBT as a stand-
alone modality for breast cancer screening may be feasible,
since the added value of the other DBT view or any DMviews
was not found significant in this study. Aside from theMalmö
Breast Tomosynthesis Screening Trial, which was performed
with 1v-DBT [7], most screening trials with DBT have used a
protocol consisting of 2v-DBTwith narrow-angle systems [3,
17, 18, 34, 19]. All studies report equivalent increases in
breast cancer detection rates, and similar recall rates [11].
Screening is different from clinical practice. A mass screening
policy always implies compromises due to constraints of
costs, staffing, radiation dose to the population and other fac-
tors. In clinical practice, such constraints are less of an issue.
The Malmö Study showed a 43 % increase in cancer de-
tection rate with 1v-DBT compared with 2v-DM. Clearly,
adding a CC-view in DBTwould increase the cancer detection
rate marginally, just as e.g. adding breast ultrasound examina-
tion would do, something that is usually considered not feasi-
ble except in high risk groups. In the future, screening is in all
likelihood going to be individualized based on risk profile.
Fig. 5 Example of a patient with
a ductal carcinoma in situ grade
II. This case was recalled by three
readers and two readers with 1v-
DBT and 2v-DBT/2v-DM, re-
spectively, and it was not recalled
by any reader with 2v-DM: (i)
MLO tomosynthesis slice where
the lesion is in focus. (ii) MLO
mammography
Fig. 4 Average (a) sensitivity and
(b) specificity (in %) on each
imaging protocol, for all the
readers as well as differentiating
by level of experience. Error bars
indicate Wald 95 % confidence
intervals. Significant differences
with respect to 1v-DBT are indi-
cated with a (*)
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High-risk groups will probably be offered something increas-
ing the sensitivity which may be another DBT view, ultra-
sound or even MRI, the latter already being the case in many
programs for women with the highest risk. Nevertheless, in a
screening scenario, we assume that if 2v-DBT is not feasible
due to implementation reasons, there is an overall benefit in
detection achieved by performing 1v-DBT instead of two-
view DM. Finally, it is yet to be seen if 1v-DBT with a
narrow-angle DBT system yields at least the same perfor-
mance as 2v-DM for breast cancer detection, something not
assessed in this work due to its single manufacturer limitation.
The increased reading time for DBT in comparison to DM
is still one of the pitfalls that can be improved before
implementing DBT in a screening setup [15, 35]. Certainly,
Fig. 7 Example of a patient with
an invasive ductal carcinoma with
ductal carcinoma in situ grade II,
who was recalled by only one
reader with 1v-DBT, by four
readers with 2v-DBT/2v-DM,
and by all six readers with 2v-
DM: (i) MLO tomosynthesis slice
where the lesion is in focus. (ii)
CC mammography
Fig. 6 Example of a patient with
a sclerosed fibroadenoma,
recalled by one reader with 1v-
DBT, by one reader with 2v-
DBT/2v-DM, and recalled by all
six readers with 2v-DM: (i) MLO
tomosynthesis slice where the le-
sion is in focus. (ii) MLO and CC
mammograph
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using one-view instead of two-view DBT, without losing clin-
ical performance, could ameliorate this problem.We observed
that 1v-DBT took on average 25% longer to read than 2v-DM
(although for half of the observers reading times were equiv-
alent). Yet, it is also possible that longer loading times of DBT
in comparison with DM influenced reading times in our study.
Additional training of radiologists on reading DBT, the inclu-
sion of synthetic mammograms and computer aided detection
systems might aid speeding the reading of DBT.
The main limitation of our study is the fact that around 50
% of the positive cases in our dataset are recalls from the
Dutch DM-based screening program. Therefore, these were
lesions already seen in 2v-DM. The lack of a true DBTscreen-
ing population in our study, or at least enrichment with lesions
first detected with either modality, leads to a bias towards 2v-
DM, and thus the true benefit of 1v-DBT in screening might
be larger than documented in our study. The real sensitivity
and specificity of 1v-DBT in screening practice can only be
assessed in a screening study, but our study in contrast allows
determination of the relative differences in reading mode. We
included all the cancer cases available at our institution, but
the study could have benefitted from additional cases detected
by DBT screening programs. Also, there were two different
sets of radiologists involved in the readings, who might have
different operating points based on local routine. Another mi-
nor limitation may be the stepwise nature of the first reading
session, rather than dividing into three different sessions.
However, we believe the stepwise scheme could introduce a
bias, if at all, against 1v-DBT, which does not affect the con-
clusion of this work.
Conclusion
Detection performance with 1v-DBT is not statistically inferi-
or to the standard protocols of 2v-DM and 2v-DM+2v-DBT,
and its use as a stand-alone modality might be sufficient for
readers experienced with this protocol. Based upon the overall
equivalent performance in terms of ROC and JAFROC anal-
ysis, experience with single-view DBT interpretation might
change the operating point of radiologists, making their
sensitivity/specificity performance in a screening scenario
Table 5 Reading time (in seconds, mean value and 95 % CI within
parentheses) for each reader and on average, compared between 1v-
DBT and 2v-DM. Outliers greater than 1.5 times the standard deviation
of the data were removed
Reader 1v-DBT 2v-DM p-value
R1 58 (52–65) 36 (32–40) <0.001
R2 57 (52–63) 51 (46–57) 0.095
R3 42 (37–47) 46 (40–53) 0.281
R4 (exp) 63 (55–71) 64 (56–71) 0.880
R5 (exp) 56 (50–62) 31 (27–35) <0.001
R6 (exp) 55 (48–62) 35 (30–40) <0.001
Average 55 (52–59) 44 (40–48) <0.001
Fig. 8 Example of a patient with
a fibroadenoma, recalled by four
readers with 1v-DBT, by three
readers with 2v-DBT/2v-DM,
and only recalled by one reader
with 2v-DM (all readers marked
the lesion in all the modalities): (i)
MLO tomosynthesis slice where
the lesion is in focus. (ii) MLO
and CC mammography
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Therefore, with a wide-angle system and appropriate training,
MLO view-only DBT might be feasible for breast cancer
screening.
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